The study results demonstrate that tt-Mfn-EV uptake by tumor cells is receptor-mediated and occurs specifically via the TfR and blocking TfR with exogenous Tf ligand abrogates the cell cytotoxicity. The gene discussed is TF; the disease is neoplasm.